A study to assess the amount of drug levels in blood and safety of AZD5718 formulations in healthy volunteers

Trial Identifier: D7550C00008
Sponsor: AstraZeneca
NCTID:: NCT04210388
Start Date: January 2020
Primary Completion Date: March 2020
Condition: Heart Condition

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version

Trial Locations

Country Location
United Kingdom Harrow, United Kingdom, HA1 3UJ